CRDF Cardiff Oncology, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 11, 2026
$1.12
· of 52w range
· above low
· to high
$0.7652w low
$3.3152w high
Market Cap (MRQ)
$77M
P/E (TTM)
-1.9
EPS (TTM)
$-0.60
Revenue (TTM)
$508.0K
your badges
52W Range
$1–$3
Analyst Rating
BUY
Price Target
$6
P/E
-1.9
ROE
-94.1%
Net Profit Margin
-7884.1%
Your badge strip is empty — pin a metric anywhere on this page.
CRDF Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.12
Market Cap (MRQ)
$77M
P/E (TTM)
-1.9
EPS (TTM)
$-0.60
Revenue (TTM)
$508.0K
ROE (TTM)
-94.1%
52W Range
$1–$3
CRDF Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Feb. 20, 2019 | 1-for-6 | Reverse |
| June 4, 2018 | 1-for-12 | Reverse |
| May 30, 2012 | 1-for-6 | Reverse |
| July 27, 2004 | 111-for-1 | Forward |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$593.0K2016-12-31 → 2025-12-31
EPS$-0.692016-12-31 → 2025-12-31
Free Cash Flow$-38M2016-12-31 → 2025-12-31
Net margin-7884.1%2016-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CRDF | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -1.95Y avg ≈-4.0 | ≈-4.0 | · | · | |
| P/S (TTM) | 151.05Y avg ≈349.3 | ≈349.3 | 70.6 | Overvalued | |
| P/B (MRQ) | 2.95Y avg ≈2.2 | ≈2.2 | 2.3 | Overvalued | |
| Price / FCF | -2.05Y avg ≈-5.5 | ≈-5.5 | · | · | |
| Price / Cash Flow | -2.05Y avg ≈-5.5 | ≈-5.5 | · | · | |
| Price / Tangible Book | 1.75Y avg ≈2.2 | ≈2.2 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | CRDF | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -8320.1%5Y avg ≈-8612.0% | ≈-8612.0% | -749.2% | Weak | |
| EBITDA Margin (TTM) | -8251.0%5Y avg ≈-8534.2% | ≈-8534.2% | -749.2% | Weak | |
| Pretax Margin | -7732.0% | · | -1847.2% | Weak | |
| Net Profit Margin (TTM) | -7884.1%5Y avg ≈-8156.6% | ≈-8156.6% | -767.3% | Weak | |
| ROA (TTM) | -70.8%5Y avg ≈-39.9% | ≈-39.9% | -26.7% | Weak | |
| ROE (TTM) | -94.1%5Y avg ≈-53.8% | ≈-53.8% | -61.5% | Weak | |
| ROIC | -107.9% | · | -55.9% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CRDF | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 3.35Y avg ≈10.9 | ≈10.9 | 5.0 | Low liquidity | |
| Quick Ratio (MRQ) | 3.25Y avg ≈10.6 | ≈10.6 | 3.3 | In line |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | CRDF | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -13.2%5Y avg ≈11.8% | ≈11.8% | · | · | |
| Revenue CAGR 3Y | 15.4%5Y avg ≈16.5% | ≈16.5% | · | · | |
| Revenue CAGR 5Y | 10.1% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | CRDF | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.05Y avg ≈0.0 | ≈0.0 | 0.0 | Weak | |
| Receivables Turnover | 1.25Y avg ≈1.0 | ≈1.0 | · | · | |
| Revenue / Employee | ≈$19.8K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
5.5%
Next Report
Nov 04, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Jul 27, 2026 | $-0.14 | $-0.16 | 14.9% |
| March 31, 2026 | May 14, 2026 | $-0.18 | $-0.14 | -31.1% |
| Dec. 31, 2025 | $-0.11 | $-0.19 | 42.6% | |
| Sept. 30, 2025 | $-0.17 | $-0.21 | 18.5% | |
| June 30, 2025 | $-0.21 | $-0.20 | -6.9% | |
| March 31, 2025 | $-0.20 | $-0.19 | -5.3% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $593.0K | $683.0K | $488.0K | $386.0K | $359.0K | $366.0K | $244.6K | $378.3K | $505.4K | $381.1K | $312.8K | $280.2K | |
| Cost of Revenue | · | · | · | · | · | · | $0 | $597.5K | $2M | $2M | $629.2K | $15.4K | |
| R&D Expense | · | · | · | $27M | $17M | $11M | · | · | · | · | · | · | |
| SG&A Expense | $14M | $12M | $13M | $13M | $12M | $8M | $6M | $8M | $14M | $11M | $8M | $6M | |
| Operating Expenses | $50M | $49M | $46M | $40M | $29M | $19M | $17M | $17M | $26M | $41M | $26M | $15M | |
| Operating Income | $-49M | $-49M | $-45M | $-40M | $-29M | $-19M | $-17M | $-17M | $-26M | $-40M | $-25M | $-15M | |
| Interest Expense | · | · | · | · | $0 | $2.0K | $0 | $25.4K | $1M | $2M | $2M | $843.3K | |
| Interest Income | $3M | $3M | $4M | $2M | $264.0K | $90.0K | $234.2K | $219.4K | $147.9K | $298.8K | · | · | |
| Other Non-op | $5.0K | $-39.0K | $-98.0K | $1M | $564.0K | $-221.0K | · | · | · | · | · | · | |
| Pretax Income | $-46M | $-45M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-46M | $-45M | $-41M | $-39M | $-28M | $-19M | $-16M | $-16M | $-25M | $-39M | $-27M | $-14M | |
| EPS (Basic) | $-0.69 | $-0.95 | $-0.93 | $-0.89 | $-0.73 | $-1.08 | · | $-8.26 | $-51.76 | $-1.30 | $-1.05 | $-0.76 | |
| EPS (Diluted) | $-0.69 | $-0.95 | $-0.93 | $-0.89 | $-0.73 | $-1.08 | · | $-8.26 | $-51.76 | $-1.37 | $-1.21 | $-0.88 | |
| Shares (Basic) | 66,841,000 | 47,650,000 | 44,677,000 | 43,600,000 | 39,030,000 | 20,875,000 | 5,973,906 | 2,330,180 | 481,672 | 30,174,838 | 26,201,713 | 18,904,280 | |
| Shares (Diluted) | 66,841,000 | 47,650,000 | 44,677,000 | 43,600,000 | 39,030,000 | 20,875,000 | · | 2,330,180 | 481,672 | 30,281,263 | 26,452,165 | 19,071,112 | |
| EBITDA | $-49M | $-48M | $-45M | $-40M | $-28M | $-19M | $-16M | $-16M | $-24M | $-39M | $-25M | $-15M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17M | $51M | $22M | $16M | $12M | $131M | $10M | $11M | $8M | $14M | $67M | $67M | |
| Short-term Investments | $41M | $40M | $53M | $89M | $129M | $0 | · | · | $0 | $24M | $0 | · | |
| Receivables | $182.0K | $773.0K | $288.0K | $771.0K | $535.0K | $320.0K | $203.5K | $167.8K | $77.1K | $100.5K | $98.7K | $56.7K | |
| Prepaid Expense | $2M | $3M | $2M | $5M | $5M | $2M | $955.0K | $1M | $1M | $956.6K | $789.3K | $369.3K | |
| Current Assets | $60M | $95M | $77M | $111M | $146M | $133M | $11M | $13M | $9M | $39M | $68M | $28M | |
| PP&E (Net) | $578.0K | $898.0K | $1M | $1M | $382.0K | $624.0K | $877.8K | $1M | $2M | $4M | $3M | $840.4K | |
| PP&E (Gross) | $5M | $5M | $5M | $5M | $4M | $4M | $3M | $3M | $4M | $6M | $4M | $1M | |
| Accum. Depreciation | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $854.8K | $533.9K | |
| Other Non-current Assets | $549.0K | $69.0K | $1M | $1M | $239.0K | $404.0K | $157.6K | $102.8K | $389.9K | $1M | $374.0K | $336.7K | |
| Total Assets | $62M | $97M | $82M | $116M | $150M | $135M | $13M | $14M | $12M | $44M | $71M | $29M | |
| Accounts Payable | $8M | $5M | $2M | $2M | $1M | $1M | $656.3K | $664.8K | $825.2K | $1M | $1M | $747.8K | |
| Accrued Liabilities | $8M | $8M | $8M | $5M | $5M | $4M | $3M | $2M | $1M | $4M | $2M | $2M | |
| Short-term Debt | · | · | · | · | · | · | $0 | · | · | · | · | · | |
| Current Liabilities | $16M | $13M | $10M | $8M | $7M | $6M | $5M | $3M | $4M | $8M | $8M | $4M | |
| Capital Leases | $102.0K | $813.0K | $1M | $2M | $3M | $9.0K | $861.0K | $0 | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $0 | $156.0K | $128.4K | $42.0K | · | · | $0 | · | |
| Total Liabilities | $16M | $14M | $12M | $10M | $9M | $7M | $6M | $4M | $6M | $24M | $23M | $21M | |
| Common Stock | $7.0K | $7.0K | $4.0K | $4.0K | $4.0K | $4.0K | $8.3K | $7.7K | $5.3K | $3.1K | $3.0K | $1.9K | |
| Paid-in Capital | $475M | $467M | $409M | $405M | $401M | $362M | $217M | $202M | $180M | $168M | $158M | $90M | |
| Retained Earnings | $-430M | $-384M | $-340M | $-298M | $-260M | $-231M | $-209M | $-192M | $-173M | $-148M | $-109M | $-81M | |
| AOCI | $50.0K | $34.0K | $-67.0K | $-395.0K | $-142.0K | $0 | · | · | $0 | $-10.8K | $0 | · | |
| Stockholders' Equity | $45M | $83M | $70M | $106M | $140M | $128M | $7M | $10M | $7M | $20M | $49M | $8M | |
| Liabilities + Equity | $62M | $97M | $82M | $116M | $150M | $135M | $13M | $14M | $12M | $44M | $71M | $29M | |
| Shares Outstanding | 68,305,000 | 66,524,000 | 44,677,000 | 44,677,000 | 41,964,000 | 36,781,000 | 8,593,633 | 3,831,879 | 733,217 | 30,696,791 | 29,737,601 | 18,915,793 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $364.0K | $404.0K | $398.0K | $236.0K | $451.0K | $466.0K | $494.2K | $859.5K | $1M | $1M | $378.7K | $234.8K | |
| Stock-based Comp | $6M | $5M | $5M | $4M | $3M | $2M | $884.9K | $2M | $4M | $8M | $4M | $2M | |
| Deferred Tax | $-9M | $-9M | $-9M | $24M | $-6M | $-4M | $-3M | $-4M | $13M | $-17M | $-11M | $-6M | |
| Restructuring | · | · | · | · | · | · | $0 | $664.7K | $2M | $790.4K | $0 | $0 | |
| Other Non-cash | $11M | $12M | $15M | $-24M | $8M | $5M | $5M | $4M | $-17M | $16M | $12M | $-706.9K | |
| Operating Cash Flow | $-38M | $-38M | $-31M | $-34M | $-23M | $-16M | $-13M | $-13M | $-23M | $-31M | $-22M | $-13M | |
| CapEx | $44.0K | $80.0K | $582.0K | $1M | $205.0K | $211.0K | $67.6K | $5.1K | $101.1K | $823.5K | $2M | $363.3K | |
| Investing Cash Flow | $1M | $14M | $36M | $38M | $-131M | $-211.0K | $-67.6K | $22.8K | · | · | · | · | |
| Debt Issued | · | · | · | · | $0 | $305.0K | $0 | · | $0 | $8M | $0 | $15M | |
| Net Debt Issued | · | · | · | · | $0 | $305.0K | · | $0 | $-15M | $-1M | $0 | $15M | |
| Stock Issued | $0 | $53M | · | $0 | $34M | $112M | $9M | $12M | $12M | $2M | $61M | $0 | |
| Net Stock Activity | $0 | $53M | · | $0 | $34M | $112M | $9M | $13M | $12M | $2M | $61M | · | |
| Financing Cash Flow | $3M | $54M | $0 | $75.0K | $35M | $137M | $12M | $16M | · | · | · | · | |
| Net Change in Cash | $-34M | $30M | $5M | $4M | $-119M | $121M | $-1M | $3M | · | · | · | · | |
| Taxes Paid | $1.0K | $1.0K | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-38M | $-38M | $-31M | $-35M | $-23M | $-17M | $-13M | $-13M | $-23M | $-32M | $-24M | $-13M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -8256.3% | -7123.1% | -9305.7% | -10337.3% | -8037.6% | -5214.8% | -6817.8% | -4507.6% | -5064.4% | -10534.9% | -8079.5% | -5334.2% | |
| Net Margin | -7732.0% | -6651.7% | -8492.0% | -10026.9% | -7880.5% | -5275.1% | -6709.7% | -4351.1% | -4928.1% | -10287.8% | -8782.0% | -5113.0% | |
| Pretax Margin | -7732.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -8194.9% | -7064.0% | -9224.2% | -10276.2% | -7912.0% | -5087.5% | -6615.8% | -4280.4% | -4817.6% | -10254.2% | -7958.4% | -5250.4% | |
| ROA | -57.6% | -50.8% | -41.9% | -29.1% | -19.9% | -26.1% | -120.4% | -124.4% | -88.6% | -68.0% | -54.8% | -51.1% | |
| ROE | -88.2% | -68.7% | -56.2% | -35.3% | -20.6% | -23.9% | -235.0% | -136.8% | -189.6% | -114.5% | -96.3% | -99.7% | |
| ROIC | -107.9% | · | · | · | · | · | · | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.7 | 7.1 | 7.4 | 14.3 | 22.3 | 21.8 | 2.4 | 4.3 | 2.4 | 5.0 | 8.3 | 6.2 | |
| Quick Ratio | 3.6 | 6.9 | 7.2 | 13.6 | 21.6 | 21.5 | 2.2 | 3.9 | 2.1 | 4.9 | 8.2 | 6.1 | |
| Interest Coverage | · | · | · | · | · | -12564.8 | · | -671.2 | -24.8 | · | -16.6 | -17.7 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 1.2 | 1.3 | 0.9 | 0.6 | 0.8 | 1.4 | 1.3 | 3.1 | 5.7 | 3.8 | 4.0 | 4.1 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.66 | $1.25 | $1.56 | $2.38 | $3.35 | $3.48 | $0.85 | $2.63 | $0.12 | $0.64 | $1.64 | $0.44 | |
| Revenue / Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | · | · | $0.16 | $0.01 | $0.01 | $0.01 | $0.01 | |
| Cash Flow / Share | $-0.57 | $-0.79 | $-0.69 | $-0.78 | $-0.59 | · | · | $-5.66 | $-0.67 | $-1.03 | $-0.84 | $-0.67 | |
| Cash / Share | $0.26 | $0.77 | $0.48 | $0.37 | $0.28 | $3.56 | $1.19 | $2.99 | $0.16 | $0.45 | $2.27 | $1.44 | |
| EPS (TTM) | $-0.69 | $-0.95 | $-0.93 | $-0.89 | $-0.73 | $-1.08 | $-3.62 | $-8.26 | $-51.76 | $-1.37 | $-1.21 | $-0.88 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -13.2% | 40.0% | 26.4% | 7.5% | -1.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 15.4% | 23.9% | 10.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.1% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $593.0K | $683.0K | $488.0K | $386.0K | $359.0K | $366.0K | $244.6K | $378.3K | $505.4K | $381.1K | $312.8K | $280.2K | |
| Net Income TTM | $-46M | $-45M | $-41M | $-39M | $-28M | $-19M | $-16M | $-16M | $-25M | $-39M | $-27M | $-14M | |
| Market Cap | $192M | $289M | $66M | $63M | $252M | $662M | $11M | $12M | $1.18B | $4.64B | $11.56B | $5.86B | |
| P/E | -4.1 | -4.6 | -1.6 | -1.6 | -8.2 | -16.7 | -0.3 | -0.4 | -0.4 | -110.4 | -321.3 | -351.8 | |
| P/S | 323.7 | 422.7 | 135.5 | 162.0 | 702.5 | 1807.9 | 43.6 | 32.2 | 2331.4 | 12179.7 | 36961.4 | 20902.2 | |
| P/B | 4.2 | 3.5 | 0.9 | 0.6 | 1.8 | 5.2 | 1.5 | 1.2 | 181.1 | 234.8 | 237.4 | 701.4 | |
| P / Tangible Book | 4.2 | 3.5 | 0.9 | 0.6 | 1.8 | 5.2 | · | · | · | · | · | · | |
| P / Cash Flow | -5.1 | -7.7 | -2.1 | -1.8 | -10.9 | -40.6 | -0.8 | -0.9 | -50.6 | -149.5 | -522.7 | -460.1 | |
| P / FCF | -5.1 | -7.6 | -2.1 | -1.8 | -10.8 | -40.0 | -0.8 | -0.9 | -50.4 | -145.7 | -474.6 | -447.4 | |
| Earnings Yield | -24.6% | -21.9% | -62.8% | -63.6% | -12.2% | -6.0% | -291.9% | -259.8% | -231.9% | -0.91% | -0.31% | -0.28% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $104.0K | $41.0K | $243.0K | $120.0K | $121.0K | $109.0K | $150.0K | $165.0K | $163.0K | $205.0K | $156.0K | $141.0K | $108.0K | $83.0K | $128.0K | $93.0K | |
| SG&A Expense | $4M | $6M | $3M | $4M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | |
| Operating Expenses | $10M | $13M | $8M | $12M | $15M | $14M | $13M | $13M | $13M | $11M | $10M | $11M | $12M | $12M | $10M | $9M | |
| Operating Income | $-10M | $-13M | $-8M | $-12M | $-15M | $-14M | $-13M | $-13M | $-13M | $-11M | $-10M | $-11M | $-12M | $-12M | $-9M | $-9M | |
| Interest Income | $382.0K | $506.0K | $612.0K | $716.0K | $835.0K | $941.0K | $787.0K | $741.0K | $805.0K | $926.0K | $1M | $1M | $1M | $940.0K | $740.0K | $458.0K | |
| Other Non-op | $1.0K | $-1.0K | $-1.0K | $0 | $-1.0K | $7.0K | $-2.0K | $5.0K | $-38.0K | $-4.0K | $-13.0K | $21.0K | $5.0K | $-111.0K | $2M | $-36.0K | |
| Net Income | $-9M | $-12M | $-7M | $-11M | $-14M | $-13M | $-12M | $-12M | $-12M | $-10M | $-9M | $-10M | $-11M | $-11M | $-9M | $-9M | |
| EPS (Basic) | $-0.14 | $-0.18 | $-0.11 | $-0.17 | $-0.21 | $-0.20 | $-0.22 | $-0.25 | $-0.26 | $-0.22 | $-0.21 | $-0.22 | $-0.25 | $-0.25 | $-0.20 | $-0.20 | |
| EPS (Diluted) | $-0.14 | $-0.18 | $-0.11 | $-0.17 | $-0.21 | $-0.20 | $-0.22 | $-0.25 | $-0.26 | $-0.22 | $-0.21 | $-0.22 | $-0.25 | $-0.25 | $-0.20 | $-0.20 | |
| Shares (Basic) | 68,397,000 | 68,350,000 | · | 66,879,000 | 66,526,000 | 66,524,000 | · | 46,865,000 | 44,825,000 | 44,678,000 | · | 44,677,000 | 44,677,000 | 44,677,000 | · | 43,333,000 | |
| Shares (Diluted) | 68,397,000 | 68,350,000 | · | 66,879,000 | 66,526,000 | 66,524,000 | · | 46,865,000 | 44,825,000 | 44,678,000 | · | 44,677,000 | 44,677,000 | 44,677,000 | · | 43,333,000 | |
| EBITDA | $-10M | $-13M | · | · | $-15M | $-14M | · | $-13M | $-13M | $-11M | · | $-11M | $-12M | $-12M | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $9M | $17M | $10M | $11M | $24M | $51M | $13M | $26M | $19M | $22M | $15M | $19M | $15M | $16M | $19M | |
| Short-term Investments | $25M | $38M | $41M | $50M | $60M | $56M | $40M | $45M | $35M | $49M | $53M | $66M | $70M | $82M | $89M | $96M | |
| Receivables | $189.0K | $191.0K | $182.0K | $254.0K | $526.0K | $405.0K | $773.0K | $618.0K | $451.0K | $393.0K | $288.0K | $198.0K | $161.0K | $676.0K | $771.0K | $650.0K | |
| Prepaid Expense | $883.0K | $1M | $2M | $956.0K | $2M | $2M | $3M | $1M | $1M | $2M | $2M | $2M | $3M | $4M | $5M | $5M | |
| Current Assets | $36M | $47M | $60M | $62M | $74M | $83M | $95M | $59M | $62M | $70M | $77M | $84M | $93M | $102M | $111M | $120M | |
| PP&E (Net) | $450.0K | $491.0K | $578.0K | $666.0K | $743.0K | $805.0K | $898.0K | $993.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | $5M | $5M | $5M | · | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | $4M | $5M | $4M | · | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | |
| Other Non-current Assets | $927.0K | $844.0K | $549.0K | $549.0K | $401.0K | $257.0K | $69.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $184.0K | |
| Total Assets | $37M | $49M | $62M | $64M | $76M | $85M | $97M | $63M | $66M | $74M | $82M | $88M | $97M | $107M | $116M | $124M | |
| Accounts Payable | $4M | $5M | $8M | $2M | $6M | $4M | $5M | $5M | $5M | $5M | $2M | $2M | $3M | $3M | $2M | $1M | |
| Accrued Liabilities | $6M | $8M | $8M | $12M | $10M | $9M | $8M | $7M | $7M | $6M | $8M | $6M | $6M | $5M | $5M | $6M | |
| Current Liabilities | $11M | $14M | $16M | $15M | $17M | $13M | $13M | $13M | $13M | $12M | $10M | $9M | $9M | $8M | $8M | $8M | |
| Capital Leases | $0 | $0 | $102.0K | $284.0K | $464.0K | $640.0K | $813.0K | $979.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | |
| Total Liabilities | $11M | $14M | $16M | $15M | $17M | $14M | $14M | $14M | $14M | $13M | $12M | $11M | $11M | $10M | $10M | $10M | |
| Common Stock | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $478M | $477M | $475M | $472M | $470M | $468M | $467M | $422M | $413M | $410M | $409M | $408M | $407M | $406M | $405M | $404M | |
| Retained Earnings | $-452M | $-442M | $-430M | $-423M | $-412M | $-398M | $-384M | $-372M | $-361M | $-349M | $-340M | $-330M | $-320M | $-309M | $-298M | $-290M | |
| AOCI | $-62.0K | $-49.0K | $50.0K | $50.0K | $17.0K | $27.0K | $34.0K | $82.0K | $-97.0K | $-132.0K | $-67.0K | $-407.0K | $-431.0K | $-76.0K | $-395.0K | $-779.0K | |
| Stockholders' Equity | $27M | $35M | $45M | $49M | $59M | $71M | $83M | $49M | $52M | $61M | $70M | $78M | $87M | $97M | $106M | $113M | |
| Liabilities + Equity | $37M | $49M | $62M | $64M | $76M | $85M | $97M | $63M | $66M | $74M | $82M | $88M | $97M | $107M | $116M | $124M | |
| Shares Outstanding | 68,502,000 | 68,370,000 | 68,305,000 | 67,095,000 | 66,526,000 | 66,526,000 | 66,524,000 | 48,731,000 | 45,602,000 | 44,710,000 | 44,677,000 | 44,677,000 | 44,677,000 | 44,677,000 | 44,677,000 | 43,335,000 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $87.0K | $87.0K | $88.0K | $89.0K | $94.0K | $93.0K | $96.0K | $101.0K | $105.0K | $102.0K | $103.0K | $107.0K | $98.0K | $90.0K | $86.0K | $81.0K | |
| Stock-based Comp | $920.0K | $2M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $909.0K | $955.0K | $2M | $1M | $1M | $1M | |
| Other Non-cash | · | $-2M | · | · | · | $-818.0K | · | · | · | $1M | · | · | · | $1M | · | · | |
| Operating Cash Flow | $-12M | $-12M | $-6M | $-11M | $-8M | $-13M | $-10M | $-10M | $-9M | $-8M | $-7M | $-8M | $-7M | $-9M | $-9M | $-7M | |
| CapEx | · | · | $0 | $18.0K | · | · | $0 | $0 | $0 | $80.0K | $8.0K | $315.0K | $251.0K | $8.0K | $75.0K | $448.0K | |
| Investing Cash Flow | $12M | $3M | $11M | $10M | $-5M | $-15M | $5M | $-9M | $14M | $5M | $14M | $4M | $11M | $7M | $7M | $5M | |
| Stock Issued | · | · | · | · | · | · | $44M | $7M | · | · | · | · | · | · | · | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | $7M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $149.0K | $105.0K | $3M | $25.0K | $0 | $3.0K | $44M | $7M | $2M | $107.0K | · | $0 | $0 | $0 | $0 | $75.0K | |
| Net Change in Cash | $653.0K | $-9M | $7M | $-649.0K | $-13M | $-27M | $38M | $-12M | $7M | $-3M | $6M | $-4M | $4M | $-1M | $-2M | $-2M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-8M | · | · | · | $-9M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -9245.2% | -31341.5% | · | -9978.3% | -12212.4% | -13194.5% | · | -7637.0% | -7696.3% | -5333.2% | · | -7673.8% | -11303.7% | -14520.5% | · | · | |
| Net Margin | -8876.9% | -30109.8% | · | · | -11523.1% | -12324.8% | · | -7184.9% | -7225.8% | -4883.4% | · | -6901.4% | -10324.1% | -13521.7% | · | · | |
| EBITDA Margin | -9245.2% | -31129.3% | · | · | -12212.4% | -13109.2% | · | -7637.0% | -7696.3% | -5283.4% | · | -7673.8% | -11303.7% | -14412.0% | · | · | |
| ROA | -16.3% | -18.4% | · | · | -19.7% | -16.9% | · | -15.7% | -14.4% | -11.1% | · | -9.2% | -9.8% | -9.1% | · | · | |
| ROE | -21.7% | -23.4% | · | · | -25.1% | -20.4% | · | -18.6% | -17.0% | -12.7% | · | -10.2% | -10.8% | -9.9% | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 3.3 | · | · | 4.4 | 6.2 | · | 4.7 | 5.0 | 5.9 | · | 9.3 | 10.2 | 12.5 | · | · | |
| Quick Ratio | 3.2 | 3.2 | · | · | 4.3 | 6.0 | · | 4.7 | 4.9 | 5.7 | · | 9.0 | 9.8 | 12.0 | · | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Receivables Turnover | 0.3 | 0.1 | · | · | 0.2 | 0.3 | · | 0.4 | 0.5 | 0.4 | · | 0.3 | 0.3 | 0.1 | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.39 | $0.51 | · | · | $0.88 | $1.07 | · | $1.01 | $1.15 | $1.36 | · | $1.74 | $1.94 | $2.16 | · | · | |
| Revenue / Share | $0.00 | $0.00 | · | · | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | · | |
| Cash Flow / Share | · | $-0.18 | · | · | · | $-0.19 | · | · | · | $-0.17 | · | · | · | $-0.19 | · | · | |
| Cash / Share | $0.13 | $0.12 | · | · | $0.16 | $0.36 | · | $0.27 | $0.56 | $0.42 | · | $0.34 | $0.43 | $0.34 | · | · | |
| EPS (TTM) | $-0.60 | $-0.67 | · | $-0.80 | $-0.88 | $-0.93 | · | $-0.94 | $-0.91 | $-0.90 | · | $-0.92 | $-0.90 | $-0.89 | · | $-0.94 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $508.0K | $525.0K | · | $500.0K | $545.0K | $587.0K | · | $689.0K | $665.0K | $610.0K | · | $460.0K | $412.0K | $395.0K | · | $391.0K | |
| Net Income TTM | $-40M | $-45M | · | $-50M | $-51M | $-49M | · | $-43M | $-41M | $-40M | · | $-41M | $-40M | $-39M | · | $-39M | |
| Market Cap | $89M | $111M | · | · | $210M | $209M | · | $130M | $101M | $239M | · | $62M | $66M | $74M | · | · | |
| P/E | -2.2 | -2.4 | · | -2.6 | -3.6 | -3.4 | · | -2.8 | -2.4 | -5.9 | · | -1.5 | -1.6 | -1.9 | · | -1.6 | |
| P/S | 175.3 | 211.0 | · | · | 384.5 | 355.9 | · | 188.8 | 152.2 | 391.4 | · | 135.0 | 159.4 | 186.6 | · | · | |
| P/B | 3.4 | 3.2 | · | · | 3.6 | 2.9 | · | 2.6 | 1.9 | 3.9 | · | 0.8 | 0.8 | 0.8 | · | · | |
| P / Tangible Book | 3.4 | 3.2 | · | 2.8 | 3.6 | 2.9 | · | 2.6 | 1.9 | 3.9 | · | 0.8 | 0.8 | 0.8 | · | 0.6 | |
| P / Cash Flow | · | -9.0 | · | · | · | -16.3 | · | · | · | -30.8 | · | · | · | -8.5 | · | · | |
| Earnings Yield | -46.2% | -41.4% | · | -38.8% | -27.9% | -29.6% | · | -35.2% | -41.0% | -16.9% | · | -66.2% | -61.2% | -53.9% | · | -61.0% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $593.0K | $683.0K | $488.0K | $386.0K | $359.0K |
| Operating Margin % | -8256.3% | -7123.1% | -9305.7% | -10337.3% | -8037.6% |
| Net Income | $-46M | $-45M | $-41M | $-39M | $-28M |
| Diluted EPS | $-0.69 | $-0.95 | $-0.93 | $-0.89 | $-0.73 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 3.7 | 7.1 | 7.4 | 14.3 | 22.3 |
| Quick Ratio | 3.6 | 6.9 | 7.2 | 13.6 | 21.6 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-38M | $-38M | $-31M | $-35M | $-23M |
Institutional owners (13F) 118 filers · $35.8M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
118
Value held
$35.8M
New positions
21
Exited positions
29
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 21 (-3 vs prior Q) | 29 (+16 vs prior Q) | 34 (+2 vs prior Q) | 28 (-9 vs prior Q) | -6.3M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $10,459,059 | 3,722,085 | 29.23% | Shares |
| Laurion Capital Management LP | $4,027,789 | 3,098,299 | 11.26% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $3,764,270 | 2,895,592 | 10.52% | Shares |
| Pfizer Inc | $3,014,469 | 2,411,575 | 8.43% | Shares |
| FRANKLIN RESOURCES INC | $1,567,544 | 1,205,803 | 4.38% | Shares |
| BlackRock, Inc. | $1,264,735 | 972,873 | 3.53% | Shares |
| BLAIR WILLIAM & CO/IL | $1,186,267 | 912,513 | 3.32% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $1,066,639 | 820,062 | 2.98% | Shares |
| TWO SIGMA ADVISERS, LP | $1,013,005 | 360,500 | 2.83% | Shares |
| UBS Group AG | $830,309 | 638,699 | 2.32% | Shares |
| JANE STREET GROUP, LLC | $790,270 | 607,900 | 2.21% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $533,783 | 410,602 | 1.49% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $450,260 | 346,353 | 1.26% | Shares |
| STATE STREET CORP | $430,814 | 331,395 | 1.20% | Shares |
| FLPUTNAM INVESTMENT MANAGEMENT CO | $321,716 | 247,474 | 0.90% | Shares |
| MORGAN STANLEY | $319,924 | 246,095 | 0.89% | Shares |
| Callan Capital, LLC | $318,946 | 101,575 | 0.89% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $296,999 | 228,461 | 0.83% | Shares |
| CITADEL ADVISORS LLC | $239,720 | 184,400 | 0.67% | Call option |
| MARSHALL WACE, LLP | $210,879 | 162,214 | 0.59% | Shares |
| Bank of New York Mellon Corp | $210,196 | 161,689 | 0.59% | Shares |
| NORTHERN TRUST CORP | $198,738 | 152,875 | 0.56% | Shares |
| Cubist Systematic Strategies, LLC | $183,140 | 88,903 | 0.51% | Shares |
| Avestar Capital, LLC | $176,989 | 136,145 | 0.49% | Shares |
| MILLENNIUM MANAGEMENT LLC | $174,872 | 134,517 | 0.49% | Shares |
| Qube Research & Technologies Ltd | $163,215 | 125,550 | 0.46% | Shares |
| GOLDMAN SACHS GROUP INC | $157,076 | 120,827 | 0.44% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $150,979 | 116,138 | 0.42% | Shares |
| AlphaCore Capital LLC | $141,041 | 108,493 | 0.39% | Shares |
| XTX Topco Ltd | $126,620 | 97,400 | 0.35% | Shares |
| Squarepoint Ops LLC | $124,917 | 96,090 | 0.35% | Shares |
| JANE STREET GROUP, LLC | $105,300 | 81,000 | 0.29% | Call option |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $93,674 | 72,057 | 0.26% | Shares |
| Assenagon Asset Management S.A. | $87,400 | 67,231 | 0.24% | Shares |
| WOLVERINE TRADING, LLC | $84,448 | 40,600 | 0.24% | Call option |
| CAPSTONE INVESTMENT ADVISORS, LLC | $66,547 | 51,190 | 0.19% | Shares |
| Mariner, LLC | $64,163 | 49,356 | 0.18% | Shares |
| Creative Planning | $62,526 | 48,097 | 0.17% | Shares |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | $62,400 | 48,000 | 0.17% | Shares |
| TWO SIGMA INVESTMENTS, LP | $61,966 | 47,666 | 0.17% | Shares |
| IEQ CAPITAL, LLC | $58,019 | 44,630 | 0.16% | Shares |
| Glenview Trust Co | $56,066 | 43,128 | 0.16% | Shares |
| WOLVERINE TRADING, LLC | $52,832 | 25,400 | 0.15% | Put option |
| DIMENSIONAL FUND ADVISORS LP | $47,645 | 36,650 | 0.13% | Shares |
| HighTower Advisors, LLC | $45,193 | 34,764 | 0.13% | Shares |
| RHUMBLINE ADVISERS | $39,083 | 30,064 | 0.11% | Shares |
| Point72 Asset Management, L.P. | $36,901 | 28,385 | 0.10% | Shares |
| HSBC HOLDINGS PLC | $36,825 | 28,996 | 0.10% | Shares |
| Quadrature Capital Ltd | $34,927 | 26,867 | 0.10% | Shares |
| Vanguard Global Advisers, LLC | $32,852 | 25,271 | 0.09% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Acorn Bioventures, L.P., Acorn Capital Advisors, GP, LLC, Anders Hove ×2 filings | Jan. 26, 2023 | · | Initial filing | · | SEC |
| Bridger Management, LLC, Roberto Mignone | April 5, 2016 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 30 insiders · 13 officers · 13 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Mani Mohindru | Chief Executive Officer | July 14, 2026 P | 59,067 | 2 | 0 | $80,062 |
| Mark Erlander | Chief Executive Officer | March 11, 2025 A | 24,481 | 0 | 0 | $0 |
| William J Welch | Chief Executive Officer | Jan. 30, 2018 M | 842,645 | 0 | 0 | $0 |
| Joshua B Muntner | Chief Financial Officer | April 6, 2026 A | · | 0 | 0 | $0 |
| James E. Levine | Chief Financial Officer | March 11, 2025 A | 67,716 | 0 | 0 | $0 |
| Steve Zaniboni | Former CFO | April 21, 2016 M | 96,968 | 0 | 0 | $0 |
| Ajay Aggarwal | Chief Operating Officer | April 27, 2026 A | · | 0 | 0 | $0 |
| Vicki Kelemen | Exec. VP and COO | March 15, 2023 A | 6,053 | 0 | 0 | $0 |
| Tod Smeal | Chief Scientific Officer | April 14, 2026 A | · | 0 | 0 | $0 |
| Brigitte Ute Lindsay | Chief Accounting Officer | Feb. 13, 2026 A | · | 0 | 0 | $0 |
| Fairooz Kabbinavar | Chief Medical Officer | March 11, 2025 A | · | 0 | 0 | $0 |
| Katherine L Ruffner | Chief Medical Officer | March 9, 2022 A | · | 0 | 0 | $0 |
| Matthew L. Posard | Chief Commercial Officer | Jan. 4, 2016 A | · | 0 | 0 | $0 |
| Gary W Pace | Director | July 14, 2026 P | 2,043,661 | 2 | 0 | $1,040,036 |
| Lale White | Director | June 11, 2026 A | 113,788 | 0 | 0 | $0 |
| Renee P Tannenbaum | Director | June 11, 2026 A | 20,000 | 0 | 0 | $0 |
| Rodney S Markin | Director | June 11, 2026 A | 23,879 | 0 | 0 | $0 |
| James O Armitage | Director | June 11, 2026 A | 13,000 | 0 | 0 | $0 |
| Athena Countouriotis | Director | June 20, 2019 A | · | 0 | 0 | $0 |
| Stanley Tennant | Director | June 8, 2018 P | 28,839 | 0 | 0 | $0 |
| Paul Billings | Director | Jan. 23, 2018 A | 23,165 | 0 | 0 | $0 |
| Carl B Feldbaum | Director | March 17, 2015 A | · | 0 | 0 | $0 |
| Christopher Mcguigan | Director | Feb. 14, 2013 A | · | 0 | 0 | $0 |
| Robert Merrill Hunter | 10% owner | April 13, 2012 P | 5,065,004 | 0 | 0 | $0 |
| John P Brancaccio | · | June 9, 2022 J | 12,260 | 0 | 0 | $0 |
| Gary S Jacob | · | June 10, 2021 J | 21,922 | 0 | 0 | $0 |
| Thomas Adams PHD | · | June 10, 2021 J | 18,875 | 0 | 0 | $0 |
| Antonius Schuh | · | Jan. 4, 2016 A | 20,000 | 0 | 0 | $0 |
| Gabriel Cerrone | · | July 26, 2013 A | 719,526 | 0 | 0 | $0 |
| Kira Sheinerman | · | Aug. 13, 2008 P | 909,090 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 4 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
CRDF Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 12 analysts
BUY
Median target
$6.00
+435.7%
2 16.7%
Strong Buy
5 41.7%
Buy
5 41.7%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
7 analysts · 2026-10-01Mean target $5.81 +419.1%
← Below all targets
Current price $1.12
Low$1.20
Mean$5.81
High$12.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CRDF | $192M | -4.1 | -13.2% | -7732.0% | -88.2% | · |
| BMEA | $90M | -1.1 | -67.1% | -3326.0% | -216.6% | · |
| CNXU | · | · | · | · | · | · |
| ATRA | $132M | 7.0 | -6.3% | 27.1% | -88.9% | · |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | · |
| EQ | $95M | -4.0 | 13.9% | · | -133.1% | · |
| MNOV | $64M | -5.5 | · | -2928.8% | -27.1% | · |
| ICCC | · | -51.2 | 4.3% | · | · | · |
| ACRV | $76M | -1.2 | · | · | -61.0% | · |
| SERA | · | -4.4 | 5.2% | -39417.3% | -39.0% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 11, 2026